Study of Varsetatug Masetecan in Combination With Anti-Cancer Therapies in Colorectal Cancer

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a non-registrational Phase 1/2, multicenter, open-label trial to evaluate the efficacy and safety of varsetatug masetecan combined with anti-cancer therapies in participants with unresectable metastatic colorectal cancer in the second line treatment setting.
Epistemonikos ID: cc5c1b01ef522924d2217a63f701b5e6fa1003d3
First added on: Oct 29, 2026